Audit of Lymph Node Sampling in Colorectal Carcinoma Resections-implication for Prognosis and Management
Journal of Cancer and Tumor International,
Aims: To review lymph node yield in colorectal carcinoma (CRC) resections and its associated factors in a Nigerian Teaching Hospital practice.
Study design: This was a retrospective cross-sectional study.
Place and duration of study: Department of Pathology, University College Hospital Ibadan Nigeria and colectomies from January 2014 to December 2018 were reviewed.
Methodology: Surgical Pathology reports of CRC resections at the University College Hospital Ibadan over 5 years (2014-2018) were reviewed. Colectomy lengths, tumour location (colon/rectum), tumour size, comment on presence of lymph node (yes/no), lymph node count, presence of attached mesentery (yes/no), histological subtype, tumour grade, presence of tumour-positive node and count, and pT stage were documented. Fisher’s Exact test was employed to test the effects of these variables on presence of lymph node and tumour-positive node at histology using SPSS 20. Significance level was set at P < .05.
Results: Of 66 histology reports retrieved, 62 (93.9%) had comments on search for lymph nodes and attached mesentery was documented in 25 (37.9%). The median colectomy length and tumour size were 25cm (6cm-152cm) and 6.75cm (3-30cm) respectively. Lymph nodes were present in 52 (78.8%) specimens; 28 (53.8%) of these had tumour-positive lymph nodes. Adenocarcinoma NOS was the commonest histological subtype 53 (80.3%), mucinous carcinoma 12 (18.2%) and signet ring carcinoma 1 (1.5%). Eighteen, 9 and 1of adenocarcinoma NOS, mucinous carcinoma, and signet ring carcinoma respectively had tumour-positive lymph nodes. Finding of lymph node was significantly associated with comment on search for lymph node (p < .01) while finding tumour-positive nodes was associated with histological subtype, presence of mesentery, late tumour stage and lymph node count ≥ 12 (p < .05).
Conclusion: If lymph nodes were present, more than likely there will be metastatic involvement. To increase Lymph node yield in CRC resections, submission of mesentery and search for lymph nodes is indicated. When nodes are absent, a mention is required for practice audit. It is imperative to include both clinical and grossing notes for lymph nodes to certify and guide precise staging of the cancer.
- lymph node yield
- lymph node count
- Colorectal carcinoma
- tumour staging
How to Cite
Ogunbiyi JO, Fabowale AO, Ladipo AA, Ogun GO, Adeyemi AO BO. Cancer incidence and Top ten Cancers in Ibadan (Eleven Local Government Area), Childhood Cancers -Nigeria, 2009-2012; 2016.
Rafiemanesh H, Mohammadian-hafshejani A, Sepehri Z, Shamlou R, Salehiniya H, Makhsosi BR. Incidence and Mortality of Colorectal Cancer and Relationships with the Human Development Index across the World. Acian Pac J Cancer Prev. 2016;17(5):2465–73.
Jemal A, Smith RA, Ward E. Worldwide Variations in Colorectal Cancer. CA Cancer J Clin. 2009;59:366–78.
Sylla BS, Wild CP. A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent ? IJC. 2012;250:245–50.
Brierley JD, Gospodarowicz MK, Wittekind C. Colon and Rectum. In: TNM Classification of Malignant Tumours. 8th ed. 2017;84–8.
Tsai H, Huang C, Yeh Y, Ma C, Chen C. Factors affecting number of lymph nodes harvested and the impact of examining a minimum of 12 lymph nodes in stage I-III colorectal cancer patients : a retrospective single institution cohort study of 1167 consecutive patients. BMC Surg [Internet]. 2016;1–9.
Chen HH, K DC. Pathological examination of 12 regional lymph nodes and long-term survival in stages I – III colon cancer patients: An analysis of 2 , 056 consecutive patients in two branches of same institution. 2010;1333–41.
Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, Macdonald JS, et al. Accuracy of Determining Nodal Negativity in Colorectal Cancer on the Basis of the Number of Nodes Retrieved on Resection. 2003;10(3):213–8.
Shia J, Wang H, Nash GM, Klimstra DS. Lymph Node Staging in Colorectal Cancer : Revisiting the Benchmark of at Least 12 Lymph Nodes in R0 Resection. ACS [Internet]. 2012;214(3):348–55.
Wu Z, Qin G, Zhao N, Jia H, Zheng X. Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scores. 2017;1–7.
Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H, Naakamura SI, et al. Tumours of the colon and rectum. In: WHO Classification of Tumours of the Digestive System. 2010;131–82.
Ong MLH, Schofield JB, Ong MLH, Schofield JB, Hospital M, Me K. Assessment of lymph node involvement in colorectal cancer. World J Gastrointest Surg. 2016;8(3):179–92.
Lykke J, Rosenberg J, Jess P, Roikjaer O, Colorectal D, Group C. Lymph node yield and tumour subsite are associated with survival in stage I – III colon cancer: Results from a national cohort study. 2019;1–8.
Da Costa DW, van Dekken H, Witte BI, van Wagensveld BA, van Tets WF, Van Vrouenraets BC. Lymph Node Yield in Colon Cancer: Individuals Can Make the Difference. Dig Surg. 2015;32:269–74.
Lykke J, Jess P, Roikjaer O. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study. Dis Colon Rectum. 2015;58(9):823–30.
Orsenigo E, Gasparini G, Carlucci M. Clinicopathological Factors Influencing Lymph Node Yield in Colorectal Cancer: A Retrospective Study. Gastroenterol Res Pract; 2019.
Elsheikh S, Zaitoun M. Factors Influence Lymph Node Retrieval after Resection for Rectal Cancer. J Adenocarcinoma. 2016;1(2):1–7.
Destri GL, Carlo I Di, Scilletta R, Scilletta B, Puleo S, Destri GL, et al. Colorectal cancer and lymph nodes : The obsession with the number 12. World J Gastroenterol. 2014;20(8):1951–60.
Backes Y, Elias SG, Bhoelan BS, Groen JN, Bergeijk J Van, Seerden TCJ, et al. The prognostic value of lymph node yield in the earliest stage of colorectal cancer : a multicenter cohort study. 2017;1–11.
Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): Results from a multicentre , randomised controlled , non-inferiority trial. Lancet Oncol [Internet]. 2012;13(6):616–21.
Fugita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II / III Lower Rectal Cancer (JCOG0212). Ann Surg. 2017;266(2):201–7.
Abdelkhalek M, Setit A, Bianco F, Belli A, Denewer A, Youssef TF, et al. Coloproctology complete mesocolic excision with central vascular ligation in comparison with conventional surgery for patients with colon cancer – the experiences at two centers coloproctology. Ann Coloproctol. 2018;34(4):180–6.
Perrakis A, Vassos N, Weber K, Matzel KE, Papadopoulos K, Koukis G, et al. Clinical research Introduction of complete mesocolic excision with central vascular ligation as standardized surgical treatment for colon cancer in Greece. Results of a pilot study and bi-institutional cooperation. Arch Med Sci. 2019;15(5):1269–77.
Hsu T, Lu H, Wei C, Yin W, Chang C, Chiou W, et al. Clinical and pathologic factors affecting lymph node yields in colorectal cancer. PLoS One. 2013;8(7):7–11.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X, et al. Global surveillance of cancer survival 1995 – 2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet [Internet].;385(9972):977–1010.
Abstract View: 71 times
PDF Download: 59 times